Results of activity of Chimfarm JSC (Kazakhstan) in 9 months of 2004

/IRBIS, Galina Tsalyuk, November 15, 04/ - Chimfarm JSC (Shymkent), whose securities are circulating in the official list of Kazakhstan stock exchange Inc. (KASE): shares - in "B" category, bonds - in "A" category, provided KASE with the financial statement for 9 months of 2004. Following indicators are result of the issuer's financial and economic activity in 9 months of 2004, based upon the issuer's data (th. KZT, unless otherwise specified): ---------------------------------------------------------------- As of As of Indicator Oct 1, 03 Oct 1, 04 Change,% -------------------------------- --------- --------- -------- Authorized capital (paid) 1,557,675 1,557,675 0.0 Shareholders' equity 1,887,141 1,847,450 -2.1 Total assets 4,215,236 5,468,472 +29.7 Net working capital 1,239,861 1,352,432 +9.1 Accounts receivable 535,553 819,852 +53.1 Total liabilities 2,328,095 3,621,022 +55.5 Borrowed loans (excluding bonds) 1,806,613 1,050,500 -41.9 Issued bonds - 1,466,456 - Accounts payable 521,482 551,883 +5.8 Sales volume 1,469,634 1,623,607 +10.5 Cost of goods sold 1,102,547 1,117,470 +1.4 Net income for the period 30,167 38,021 +26.0 Book value of one share, KZT 359.82 352.25 -2.1 ---------------------------------------------------------------- Relative to 9 months of 2003 company's shareholders equity has decreased by KZT39.7 m. as the result of growth of total sum of uncovered loss by 651.5 m. that was covered by growth of additional unpaid capital by 597.1 m. and borrowing of additional paid capital in the amount of 14.6 m. In comparison with 9 months of 2003 there is growth of: - assets - by KZT1.2 bn. because of growth of residual value of fixed assets (including construction in process) by 905.8 m., accounts receivable - by 284.3 m. and inventory - by 237.6 m., while other assets fell by 174.5 m.; - liabilities - by KZT1.3 bn. because of bonds floatation for 1.5 bn., growth of accounts payable by 30.4 m. that was partially covered by falling of borrowed loans volume by 203.9 m.; - sales volume - by KZT154.0 m.; - cost of goods sold - by KZT14.9 m. Net income, which Chimfarm JSC received in 9 months of 2004, exceeded the figure of similar period of 2003 by KZT7.8 m. Company's primary activities - production of drugs; quality control and conducting of certification tests of drugs, ethyl alcohol and distillery production by the laboratory, which has passed accreditation; sale of chemical-pharmaceutical preparations, medical, sanitary-hygienic means and medical makings; preparation, purchasing of medical raw stuff; production and sale of other goods. [2004-11-15]